A. Stark, A. Nabavi, H. Mehdorn, and U. Blomer, Glioblastoma multiforme???report of 267 cases treated at a single institution, Surgical Neurology, vol.63, issue.2, pp.162-169, 2005.
DOI : 10.1016/j.surneu.2004.01.028

S. Sathornsumetee and J. Rich, Designer Therapies for Glioblastoma Multiforme, Annals of the New York Academy of Sciences, vol.8, issue.1, pp.108-132, 2008.
DOI : 10.1196/annals.1444.009

A. Chi, A. Norden, and P. Wen, Antiangiogenic strategies for treatment of malignant gliomas, Neurotherapeutics, vol.72, issue.20 Suppl, pp.513-526, 2009.
DOI : 10.1016/j.nurt.2009.04.010

R. Yamanaka, Dendritic-cell- and peptide-based vaccination strategies for glioma, Neurosurgical Review, vol.23, issue.6, pp.265-273, 2009.
DOI : 10.1007/s10143-009-0189-1

D. Parsons, S. Jones, X. Zhang, J. Lin, R. Leary et al., An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008.
DOI : 10.1126/science.1164382

I. Whittle, D. Short, R. Deighton, L. Kerr, C. Smith et al., Proteomic analysis of gliomas, British Journal of Neurosurgery, vol.401, issue.17, pp.576-582, 2007.
DOI : 10.1158/0008-5472.CAN-05-4552

K. Melchior, A. Tholey, S. Heisel, A. Keller, H. Lenhof et al., Proteomic Study of Human Glioblastoma Multiforme Tissue Employing Complementary Two-Dimensional Liquid Chromatography- and Mass Spectrometry-Based Approaches, Journal of Proteome Research, vol.8, issue.10, pp.4604-4614, 2009.
DOI : 10.1021/pr900420b

A. Khalil, Biomarker discovery: A proteomic approach for brain cancer profiling, Cancer Science, vol.250, issue.2, pp.201-213, 2007.
DOI : 10.1038/nrn1518
URL : http://doi.org/10.1111/j.1349-7006.2007.00374.x

S. Saikali, T. Avril, B. Collet, A. Hamlat, J. Bansard et al., Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13R??2, gp100 and TRP-2 for immunotherapy, Journal of Neuro-Oncology, vol.2, issue.2, pp.139-148, 2007.
DOI : 10.1007/s11060-006-9220-3

S. Niclou, F. Fack, and U. Rajcevic, Glioma proteomics: Status and perspectives, Journal of Proteomics, vol.73, issue.10, pp.1823-1838, 2010.
DOI : 10.1016/j.jprot.2010.03.007

S. Gharbi, P. Gaffney, A. Yang, M. Zvelebil, R. Cramer et al., Evaluation of Two-dimensional Differential Gel Electrophoresis for Proteomic Expression Analysis of a Model Breast Cancer Cell System, Molecular & Cellular Proteomics, vol.1, issue.2, pp.91-98, 2002.
DOI : 10.1074/mcp.T100007-MCP200

G. Zhou, H. Li, D. Decamp, S. Chen, H. Shu et al., 2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers, Molecular & Cellular Proteomics, vol.1, issue.2, pp.117-124, 2002.
DOI : 10.1074/mcp.M100015-MCP200

R. Deighton, R. Mcgregor, J. Kemp, J. Mcculloch, and I. Whittle, Glioma Pathophysiology: Insights Emerging from Proteomics, Brain Pathology, vol.455, issue.7, pp.691-703, 2010.
DOI : 10.1111/j.1750-3639.2010.00376.x

M. Hiratsuka, T. Inoue, T. Toda, N. Kimura, Y. Shirayoshi et al., Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene, Biochemical and Biophysical Research Communications, vol.309, issue.3, pp.558-566, 2003.
DOI : 10.1016/j.bbrc.2003.08.029

C. Fleming, A. Nunes, and M. Sousa, Transthyretin: More than meets the eye, Progress in Neurobiology, vol.89, issue.3, pp.266-276, 2009.
DOI : 10.1016/j.pneurobio.2009.07.007

C. Park, J. Jung, S. Park, H. Jung, and B. Cho, Multifarious proteomic signatures and regional heterogeneity in glioblastomas, Journal of Neuro-Oncology, vol.65, issue.1, pp.31-39, 2009.
DOI : 10.1007/s11060-009-9805-8

L. Leandro-garcia, S. Leskela, I. Landa, C. Montero-conde, E. Lopez-jimenez et al., Tumoral and tissue-specific expression of the major human ??-tubulin isotypes, Cytoskeleton, vol.103, issue.Part 13, pp.214-223, 2010.
DOI : 10.1002/cm.20436

C. Jung, C. Foerch, A. Schanzer, A. Heck, K. Plate et al., Serum GFAP is a diagnostic marker for glioblastoma multiforme, Brain, vol.130, issue.12, pp.3336-3341, 2007.
DOI : 10.1093/brain/awm263

V. Chumbalkar, C. Subhashini, V. Dhople, C. Sundaram, M. Jagannadham et al., Differential protein expression in human gliomas and molecular insights, PROTEOMICS, vol.87, issue.4, pp.1167-1177, 2005.
DOI : 10.1002/pmic.200401202

B. Ordys, S. Launay, R. Deighton, J. Mcculloch, and I. Whittle, The Role of Mitochondria in Glioma Pathophysiology, Molecular Neurobiology, vol.5, issue.1, pp.64-75, 2010.
DOI : 10.1007/s12035-010-8133-5

C. Park, J. Jung, M. Moon, Y. Kim, J. Kim et al., Tissue Expression of Manganese Superoxide Dismutase Is a Candidate Prognostic Marker for Glioblastoma, Oncology, vol.77, issue.3-4, pp.178-181, 2009.
DOI : 10.1159/000231888

F. Ria, M. Landriscina, F. Remiddi, R. Rosselli, M. Iacoangeli et al., The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications, British Journal of Cancer, vol.84, issue.4, pp.529-534, 2001.
DOI : 10.1054/bjoc.2000.1594

S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, S. Salani et al., Identification of a Primitive Brain-Derived Neural Stem Cell Population Based on Aldehyde Dehydrogenase Activity, STEM CELLS, vol.27, issue.(suppl, pp.975-985, 2006.
DOI : 10.1634/stemcells.2005-0217

S. Deng, X. Yang, H. Lassus, S. Liang, S. Kaur et al., Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers, PLoS ONE, vol.5, issue.4, p.10277, 2010.
DOI : 10.1371/journal.pone.0010277.s004

C. Ginestier, M. Hur, E. Charafe-jauffret, F. Monville, J. Dutcher et al., ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome, Cell Stem Cell, vol.1, issue.5, pp.555-567, 2007.
DOI : 10.1016/j.stem.2007.08.014
URL : https://hal.archives-ouvertes.fr/hal-01431968

Z. Rasheed, Y. J. Wang, Q. Kowalski, J. Freed, I. Murter et al., Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma, JNCI Journal of the National Cancer Institute, vol.102, issue.5, pp.340-351, 2010.
DOI : 10.1093/jnci/djp535

E. Charafe-jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel et al., Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer, Clinical Cancer Research, vol.16, issue.1, pp.45-55, 2010.
DOI : 10.1158/1078-0432.CCR-09-1630
URL : https://hal.archives-ouvertes.fr/hal-01431949

M. Son, K. Woolard, D. Nam, J. Lee, and H. Fine, SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma, Cell Stem Cell, vol.4, issue.5, pp.440-452, 2009.
DOI : 10.1016/j.stem.2009.03.003

A. Tchoghandjian, N. Baeza, C. Colin, M. Cayre, P. Metellus et al., A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties, Brain Pathology, vol.4, issue.1, pp.211-221, 2010.
DOI : 10.1111/j.1750-3639.2009.00269.x
URL : https://hal.archives-ouvertes.fr/hal-00507521

S. Takano, R. Wadhwa, Y. Yoshii, T. Nose, S. Kaul et al., Elevated Levels of Mortalin Expression in Human Brain Tumors, Experimental Cell Research, vol.237, issue.1, pp.38-45, 1997.
DOI : 10.1006/excr.1997.3754

R. Wadhwa, S. Takano, K. Kaur, C. Deocaris, O. Pereira-smith et al., Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis, International Journal of Cancer, vol.278, issue.12, pp.2973-2980, 2006.
DOI : 10.1002/ijc.21773

Y. Iwadate, T. Sakaida, T. Hiwasa, Y. Nagai, H. Ishikura et al., Molecular Classification and Survival Prediction in Human Gliomas Based on Proteome Analysis, Cancer Research, vol.64, issue.7, pp.2496-2501, 2004.
DOI : 10.1158/0008-5472.CAN-03-1254

R. Zhang, T. Tremblay, A. Mcdermid, P. Thibault, and D. Stanimirovic, Identification of differentially expressed proteins in human glioblastoma cell lines and tumors, Glia, vol.6, issue.2, pp.194-208, 2003.
DOI : 10.1002/glia.10222

C. Garrido, M. Brunet, C. Didelot, Y. Zermati, E. Schmitt et al., Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties, Cell Cycle, vol.5, issue.22, pp.2592-2601, 2006.
DOI : 10.4161/cc.5.22.3448

F. Odreman, M. Vindigni, M. Gonzales, B. Niccolini, G. Candiano et al., Proteomic Studies on Low- and High-Grade Human Brain Astrocytomas, Journal of Proteome Research, vol.4, issue.3, pp.698-708, 2005.
DOI : 10.1021/pr0498180

H. Coe and M. Michalak, ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase, The International Journal of Biochemistry & Cell Biology, vol.42, issue.6, pp.796-799, 2010.
DOI : 10.1016/j.biocel.2010.01.009

M. Fountoulakis, R. Hardmaier, E. Schuller, and G. Lubec, Differences in protein level between neonatal and adult brain, Electrophoresis, vol.20, issue.3, pp.673-678, 2000.
DOI : 10.1002/(SICI)1522-2683(20000201)21:3<673::AID-ELPS673>3.0.CO;2-Y

G. Lubec, M. Nonaka, K. Krapfenbauer, M. Gratzer, N. Cairns et al., Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down Syndrome and Alzheimer???s disease brain is downregulated at the mRNA and dysregulated at the protein level, J Neural Transm, vol.57, pp.161-177, 1999.
DOI : 10.1007/978-3-7091-6380-1_10

R. Weitzdoerfer, M. Fountoulakis, and G. Lubec, Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down Syndrome brain, J Neural Transm, pp.95-107, 2001.
DOI : 10.1007/978-3-7091-6262-0_8

H. Yoshida, A. Watanabe, and Y. Ihara, Collapsin Response Mediator Protein-2 Is Associated with Neurofibrillary Tangles in Alzheimer's Disease, Journal of Biological Chemistry, vol.273, issue.16, pp.9761-9768, 1998.
DOI : 10.1074/jbc.273.16.9761

T. Byk, S. Ozon, and A. Sobel, The Ulip family phosphoproteins. Common and specific properties, European Journal of Biochemistry, vol.254, issue.1, pp.14-24, 1998.
DOI : 10.1046/j.1432-1327.1998.2540014.x

Y. Choi, C. Kim, T. Matsuo, C. Gaetano, R. Falconi et al., HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors, Journal of Neuro-Oncology, vol.102, issue.1, pp.19-27, 2005.
DOI : 10.1007/s11060-004-3013-3

Y. Gu, N. Hamajima, and Y. Ihara, Neurofibrillary Tangle-Associated Collapsin Response Mediator Protein-2 (CRMP-2) Is Highly Phosphorylated on Thr-509, Ser-518, and Ser-522, Biochemistry, vol.39, issue.15, pp.4267-4275, 2000.
DOI : 10.1021/bi992323h

A. Cole, F. Causeret, G. Yadirgi, C. Hastie, H. Mclauchlan et al., Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo, Journal of Biological Chemistry, vol.281, issue.24, pp.16591-16598, 2006.
DOI : 10.1074/jbc.M513344200

F. Kobeissy, A. Ottens, Z. Zhang, M. Liu, N. Denslow et al., Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats, Molecular & Cellular Proteomics, vol.5, issue.10, pp.1887-1898, 2006.
DOI : 10.1074/mcp.M600157-MCP200

R. Setsuie and K. Wada, The functions of UCH-L1 and its relation to neurodegenerative diseases, Neurochemistry International, vol.51, issue.2-4, pp.105-111, 2007.
DOI : 10.1016/j.neuint.2007.05.007

N. Karp and K. Lilley, Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes, PROTEOMICS, vol.2, issue.12, pp.3105-3115, 2005.
DOI : 10.1002/pmic.200500083

K. Engelen, A. Sifrim, P. Van-de, K. Laukens, L. Arckens et al., Alternative Experimental Design with an Applied Normalization Scheme Can Improve Statistical Power in 2D-DIGE Experiments, Journal of Proteome Research, vol.9, issue.10, pp.4919-4926, 2010.
DOI : 10.1021/pr100010u

J. Mcdonald, Handbook of Biological Statistics. 2 edition Ref Type: Generic, pp.118-122, 2009.

A. Rolland, B. Evrard, N. Guitton, R. Lavigne, P. Calvel et al., Two-Dimensional Fluorescence Difference Gel Electrophoresis Analysis of Spermatogenesis in the Rat, Journal of Proteome Research, vol.6, issue.2, pp.683-697, 2007.
DOI : 10.1021/pr060436z
URL : https://hal.archives-ouvertes.fr/hal-00653235

I. Romero-calvo, B. Ocon, P. Martinez-moya, M. Suarez, A. Zarzuelo et al., Reversible Ponceau staining as a loading control alternative to actin in Western blots, Analytical Biochemistry, vol.401, issue.2, pp.318-320, 2010.
DOI : 10.1016/j.ab.2010.02.036